Use of liver stiffness measurement for HCC risk stratification in metabolic dysfunction–associated steatotic liver disease

LSM is associated with HCC risk in MASLD. HCC surveillance should be considered in noncirrhotic MASLD with diabetes and LSM of ≥10 kPa.

Authors

Institutions

Publication Details

Journal
Hepatology
Published
2025-08-14
DOI
https://doi.org/10.1097/hep.0000000000001498
Citations
9
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
12.19
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of liver stiffness measurement for HCC risk stratification in metabolic dysfunction–associated steatotic liver disease

Amit G. Singal, Yangyang Deng, Bassam Dahman, Dustin Bastaich et al.
9 citations
Hepatology
Liver Disease Diagnosis and Treatment
12.19
article

Use of liver stiffness measurement for HCC risk stratification in metabolic dysfunction–associated steatotic liver disease

Amit G. Singal, Yangyang Deng, Bassam Dahman, Dustin Bastaich, Binu V. John
article en
9 citations

Abstract

LSM is associated with HCC risk in MASLD. HCC surveillance should be considered in noncirrhotic MASLD with diabetes and LSM of ≥10 kPa.

Hepatology
Johns Hopkins University (US), University of Miami (US), Virginia Commonwealth University (US), Miami VA Healthcare System (US), Artistic Realization Technologies (US), The University of Texas Southwestern Medical Center (US)
Openalex Percentile: Top 1%
Liver Disease Diagnosis and Treatment
12.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Use of liver stiffness measurement for HCC risk stratification in metabolic dysfunction–associated steatotic liver disease — Amit G. Singal, Yangyang Deng, et al. · Hepatology (2025) | TGRS Research Map | TGRS